Adherence in Acute Coronary Syndrome

Published Online: Monday, March 25, 2013
Follow Pharmacy_Times:
In this video, from AJMCtv, Jeffrey Berger, MD, assistant professor at NYU Langone Medical Center, discusses how research can help increase adherence to therapies among acute coronary syndrome (ACS) patients.

Related Articles
The 23 Insight Sessions featured at the 2014 NACDS Total Store Expo addressed a wide range of challenges affecting today’s pharmacy landscape.
Patients who receive statins soon after acute coronary syndrome are 24% less likely to experience unstable angina after 4 months.
Patients adhered to a novel polypill containing 3 cardiovascular medications better than if they received the medications separately, a study suggests.
Latest Issues
$auto_registration$